624 - Probability of Target Attainment of Ceftolozane/Tazobactam Among Adult Patients with Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Secondary to Pseudomonas aeruginosa in Latin America

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

Aline Okuma, PharmD

Manager
MSD Brazil, Sao Paulo, Brazil
Sao Paulo, Sao Paulo, Brazil

Thales Polis, MD

Manager
MSD Brazil, Sao Paulo, Brazil
Sao Paulo, Sao Paulo, Brazil
JP

Jacqueline Pavia, MD

Regional Director
MSD Colombia, Bogota, Colombia.
Bogota, Distrito Capital de Bogota, Colombia
Gustavo Mizuno, PharmD

MSL
MSD Brazil, Sao Paulo, Brazil
Sao Paulo, Sao Paulo, Brazil
JF

Jacqueline Ferrari, MD

MSL
MSD Brazil, Sao Paulo, Brazil
Sao Paulo, Sao Paulo, Brazil
CD

Charles A. DeRyke, PharmD

Director
Merck Research Laboratories
Longwood, Florida, United States